Similar oncogenic alterations in KRAS, NRAS and HRAS genes are strong causative drivers in a broad variety of solid and hematological tumors with mostly aggressive behavior [28]. This evidence concerns the gene NRAS and hematopoietic and lymphoid system neoplasm.